Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel :+91 40 4900 2900 Fax :+91 40 4900 2999 Email :mail@drreddys.com www.drreddys.com

Key Takeaway: Corporate Relationship Department National Stock Exchange of India Ltd. BSE Limited "Exchange Plaza" Dalal Street, Fort Bandra-Kurla Complex, Bandra (East), Mumbai - 400 001 Mumbai - 400 051 Fax Nos.: 022-22723121 / 22723719 / Fax Nos.: 022-26598120/ 26598237/ 22722037 / 22722039

Full Press Release Details

Corporate Relationship Department National Stock Exchange of India Ltd.
BSE Limited "Exchange Plaza"
Dalal Street, Fort Bandra-Kurla Complex, Bandra (East),
Mumbai - 400 001 Mumbai - 400 051
Fax Nos.: 022-22723121 / 22723719 / Fax Nos.: 022-26598120/ 26598237/
22722037 / 22722039 26598238
Scrip Code: 500124 Scrip Code: DRREDDY-EQ
Further to our intimation dated March 5,
2020 with regard to the audit of our API manufacturing plant 5 at Miryalaguda, Nalgonda district, Telangana, we would like to inform
you that we have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure
of the audit and the inspection classification of this facility is determined as "Voluntary Action Indicated" (VAI).
This is for your information.
/s/ Sandeep Poddar
Sandeep Poddar
Company Secretary
CC:- New York Stock Exchange Inc. (Stock Code: RDY)
Last updated: Apr 9, 2020